Glenmark launches Teneligliptin+Dapagliflozin Fixed-Dose Combination for adults with type-II… EP News Bureau Oct 20, 2022 The medication will be marketed under brand name Zita D
Sitagliptin combinations for diabetics to be sold at JAKs Press Information Bureau Sep 19, 2022 Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-II diabetes mellitus
Bayer introduces medication for Chronic Kidney Disease Press Trust of India Aug 26, 2022 The drug is a non-steroidal, selective mineralocorticoid receptor antagonist indicated for patients with chronic kidney disease…
Cadila Pharma launches generic Sitagliptin versions to treat uncontrolled type-II diabetes EP News Bureau Aug 1, 2022 The two generic drugs have been launched under the brand names Jankey and Sitenali
IIT Mandi discovers molecule that might help in treating type-I and type-II diabetes EP News Bureau May 3, 2022 Researchers found that the molecule PK2 not only increases insulin release, but also prevents and reverses beta cell loss, making…
US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes EP News Bureau Mar 30, 2022 Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose